Table 6 Functional scales in maintenance therapy arms 1–3, and arms 2+3 versus control arm 5
From: A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
Characteristic | Arm 1 (n = 46) | Arm 2 (n = 76) | Arm 3 (n = 42) | Arms 2+3 (n = 118) | Arm 5 (n = 80) |
|---|---|---|---|---|---|
At screening | |||||
 MS ± SD | 81.23 ± 4.42 | 82.05 ± 4.62 | 82.18 ± 4.62 | 82.09 ± 4.60 | 81.87 ± 5.16 |
 p* | 0.4464 | 0.8218 | 0.7500 | 0.7516 |  |
After combined treatment | |||||
 MS ± SD | 66.49 ± 5.10 | 67.51 ± 4.78 | 66.95 ± 4.84 | 67.32 ± 4.79 | 67.15 ± 4.92 |
 p* | 0.4440 | 0.6504 | 0.8337 | 0.8202 |  |
At the end of the study | |||||
 MS ± SD | 50.90 ± 9.74 | 55.04 ± 6.68 | 53.41 ± 7.39 | 54.41 ± 6.96 | 48.10 ± 6.09 |
 p* | 0.2122 | < 0.0001 | 0.0055 | 0.0001 |  |